Basic Information

Gene symbol CXCL12 Synonyms IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1 Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas | PertOrg
Description C-X-C motif chemokine ligand 12

GTO ID GTC1332
Trial ID NCT00976378
Disease Glioblastoma
Altered gene CXCL-12
Therapeutic/Target gene Target gene
TherapyAptamer
Treatment NOX-A12|olaptesed pegol
PhasePhase1
Recruitment statusCompleted
TitleNOX-A12 to Mobilize Stem Cells in Healthy Volunteers - A Single-center, Single Dose, Open Label, Dose Escalation Study of Intravenous NOX-A12 in up to 48 Healthy Subjects
Year2009
CountryGermany
Company sponsorTME Pharma AG
Other ID(s)SNOXA12C001

Clinical Result

Cohort1: dose level 1
Administration route intravenous infusion
Dosage 0.05~10.8 mg
Age Adult
Cohort2: dose level 2
Administration route intravenous infusion
Dosage 0.15~10.8 mg
Age Adult
Cohort3: dose level 3
Administration route intravenous infusion
Dosage 0.45~10.8 mg
Age Adult
Cohort4: dose level 4
Administration route intravenous infusion
Dosage 1.35~10.8 mg
Age Adult
Cohort5: dose level 5
Administration route intravenous infusion
Dosage 2.7~10.8 mg
Age Adult
Cohort6: dose level 6
Administration route intravenous infusion
Dosage 5.4~10.8 mg
Age Adult
Cohort7: dose level 7
Administration route intravenous infusion
Dosage 10.8~10.8 mg
Age Adult
Cohort8: dose level 6_apheresis
Administration route intravenous infusion
Dosage 5.4~10.8 mg
Age Adult

Relationship Graph

Overview of Knowledge Graph